Patents by Inventor Zoann J. Nugent

Zoann J. Nugent has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phoshorylation of Estrogen Receptor Alpha
    Publication number: 20130143750
    Abstract: The present invention provides use and methods markers based on the phosphorylation state of certain amino acid residues of estrogen receptor ?.
    Type: Application
    Filed: December 22, 2009
    Publication date: June 6, 2013
    Applicant: The University of Manitoba
    Inventors: Leigh C. Murphy, Zoann J. Nugent, Peter H. Watson, Georgios P. Skliris
  • Phoshorylation of Estrogen Receptor Alpha Serine 282 as a Marker for Endocrine Therapies in Breast Cancer
    Publication number: 20130079418
    Abstract: The present invention provides diagnostic methods and markers based on the phosphorylation state of certain amino acid residues of estrogen receptor ?. The invention relates to the phosphorylation of specific estrogen receptor alpha residues as a marker for susceptibility to chemotherapy. The invention specifically discloses the phosphorylation of serine 282 of the ER-alpha, as a diagnostic marker for breast cancer cells which are more responsive to hormone therapy than cells without the said phosphorylation.
    Type: Application
    Filed: December 22, 2009
    Publication date: March 28, 2013
    Applicant: The University of Manitoba
    Inventors: Leigh C. Murphy, Zoann J. Nugent, Peter H. Watson, Georgios P. Skliris